Skip to main content
. 2022 Aug 15;13:834627. doi: 10.3389/fendo.2022.834627

Table 1.

Demographic and stimulation data.

GnRHa group (n = 56) Dual trigger group (n = 44) hCG group (n = 53) p-value
Age, years 29 (27–33) 31 (28–33) 30 (29–33) 0.386
Body mass index, n 21.5 (20.3–24.55) 22.05 (19.6; 25.65) 22.2 (20.3–24.6) 0.874
Basal FSH, IU/L 6.15 (4.25; 7.33) 6.70 (5.3; 8.4) 6.2 (5; 8.1) 0.125
AMH, ng/ml 4.45 (3; 7.2) 3.60 (3.30; 5.06) 4.2 (2.85; 5.8) 0.351
AMH (2.5–4 ng/ml/>4 ng/ml), % 48.2%/51.8% 59.1%/40.9% 47.2%/52.8% 0.441
Infertility duration, years 4 (3–6) 3 (2; 4) 4 (3; 6) 0.095
Infertility
I
II
57.1 (32/56)
42.9 (24/56)
52.3 (23/44)
47.7 (21/44)
50.9 (27/53)
49.1 (26/53)
1.0
Infertility factors, %
- Tubal
-Male
-PCOS
-Combined
-Unexplained
33.9 (19/56)
37.5 (21/56)
16.1 (9/56)
10.7 (6/56)
1.8 (1/56)
34.1 (15/44)
31.8 (14/44)
18.2 (8/44)
13.6 (6/44)
2.3 (1/44)
37.7 (20/53)
28.3 (15/53)
22.6 (12/53)
7.6 (4/53)
3.8 (2/53)
1.0
0.215
Starting rFSH dose, IU 150 (150; 200) 150 (150; 200) 150 (150; 200) 0.918
Total rFSH dose, IU 1,500 (1,200; 1,975) 1,350 (1,000; 1,762.50) 1,600 (1,200; 1,987.5) 0.294
Number of follicles ≥11 mm on ovulation triggering day, n 17 (15; 20) 19 (16; 20) 18 (16; 20) 0.064

Values are median (25%–75%) unless otherwise noted.

PCOS, polycystic ovarian syndrome.